CLLS logo

CLLS
Cellectis

2,578
Mkt Cap
$281.35M
Volume
12,147.00
52W High
$5.48
52W Low
$1.33
PE Ratio
-5.74
CLLS Fundamentals
Price
$3.89
Prev Close
$3.91
Open
$3.89
50D MA
$3.69
Beta
1.18
Avg. Volume
53,466.83
EPS (Annual)
-$0.6761
P/B
5.14
Rev/Employee
$319,540.26
$396.59
Loading...
Loading...

About

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
229

Frequently Asked Questions

What is Market Cap of Cellectis - ADR?
What is the 52-week high for Cellectis - ADR?
What is the 52-week low for Cellectis - ADR?
What is Cellectis - ADR stock price today?
What was Cellectis - ADR stock price yesterday?
What is the PE ratio of Cellectis - ADR?
What is the Price-to-Book ratio of Cellectis - ADR?
What is the 50-day moving average of Cellectis - ADR?
How many employees does Cellectis - ADR have?

Latest CLLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.